CD19 and cancer: Although CD19 CAR-T has been highly effective against B-cell blood cancers [6,7,8], there are few reports of successful treatments for solid cancers [9,10,11,12,13,14], probably because there are few protein antigens specifically expressed on the surface of the cancer cell membrane.